Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;35(6):e15501.
doi: 10.1111/dth.15501. Epub 2022 Apr 12.

Basal cell carcinoma: An updated review of pathogenesis and treatment options

Loren E Hernandez  1 , Noreen Mohsin  1 , Nicole Levin  2 , Isabella Dreyfuss  3 , Fabio Frech  1 , Keyvan Nouri  1
Affiliations
Review

Basal cell carcinoma: An updated review of pathogenesis and treatment options

Loren E Hernandez et al. Dermatol Ther. 2022 Jun.

Abstract

Basal cell carcinoma (BCC) remains the most common malignancy worldwide. BCC pathogenesis is a result of the interplay between one's environment, genetics, and phenotypic factors. BCC has a low mortality but given its increasing incidence and potential to cause local destruction thus resulting in significant morbidity, it is vital for dermatologists to remain up to date with recent updates in this malignancy's pathogenesis and treatment. This article provides a comprehensive review of the pathogenesis of BCC as well as the current treatments available and clinical trials underway. We also touch upon the updated National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology in respect to BCC's recommended treatment modalities.

Keywords: basal cell; gorlin; hedgehog; immunotherapy; targeted therapy.

PubMed Disclaimer

References

REFERENCES

    1. Rowe DE, Carroll Rj Fau-Day CL Jr, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26:976-990.
    1. Apalla Z, Nashan D, Weller RB, Castellsague X. Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatol Ther. 2017;7(Suppl 1):5-19. doi:10.1007/s13555-016-0165-y
    1. American Cancer Society cancer statistics 2021 report. J Nucl Med. 2021;62(3):12.
    1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5 Pt 1):774-778. doi:10.1016/s0190-9622(08)81509-5
    1. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294(6):681-690.

MeSH terms

LinkOut - more resources